KAI-9803

· KAI Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KAI-9803, covering 2011-09-02 to 2011-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack] [Phase 2]

See pricing